Inova Cardiogenic Shock Registry (INOVA SHOCK)

Part of paid clinical trials in Falls Church, Virginia.

Sponsor
Inova Health Care Services
Study ID
NCT03378739
Status
Recruiting
Apply to this trial

Conditions

  • Cardiogenic Shock

Eligibility Criteria

Sex
ALL
Age
18 Years - 85 Years
Healthy Volunteers
Not accepted

Interventions

  • Cardiogenic Shock team activation — PROCEDURE
    Any patient with cardiogenic shock, whether inpatient or transferred from another facility, treated at the Inova Heart and Vascular Institute by the designated Cardiogenic Shock Team.

Study Details

To collect retrospective clinical outcomes related to acute decompensated heart failure cardiogenic shock, acute myocardial infarction cardiogenic shock and compare current versus historical survival rates. To collect Inova Heart and Vascular Institute (IHVI) site specific outcomes before and after initiation of the Cardiogenic Shock team on January 1, 2017. To collect outcomes related to implementation of mechanical circulatory support versus no circulatory intervention and type of intervention (extracorporeal membrane oxygenation (ECMO) versus intracorporeal axial-flow (Impella). • Assess survival at three time points.

Key Dates

Start date
Jan 1, 2018
Status verified
Mar 2026
Primary completion
Dec 31, 2099
Completion
Dec 31, 2099

Study Design

Enrollment
3,000 participants (estimated)

Primary Outcome Measure

Retrospective review of Cardiogenic shock patients outcomes [ Time Frame: 1 Year ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Inova Fairfax HospitalFalls ChurchVirginia22042
Behnam Tehrani, MD
Alex Truesdell, MD (PRINCIPAL_INVESTIGATOR)
Benham Tehrani, MD (SUB_INVESTIGATOR)

Find similar trials in Falls Church, VA

By research site
Inova Fairfax Hospital· Falls Church, VA

Related Studies